Invesco Private Capital provides specialized access to premiere private market investments.
Business Model:
Revenue: $6.4B
Employees: 5,001-10,000
Address: 1555 Peachtree Street, N.E.
City: Atlanta
State: GA
Zip: 30309
Country: US
Since 1981, IPC and its predecessor firms have established a reputation for excellence in investing, backing the industry-leading venture, buyout, and other private equity funds within fully discretionary commingled and separately managed accounts. IPC complements our partnership investments by deploying capital through direct investments into private companies. Over our 30+ year history, we have seen many market cycles and have demonstrated a strong track record of navigating the ever-changing marketplace. The IPC investment team is responsible for all aspects of the investment process, from deal sourcing and due diligence to investing and monitoring.
Contact Phone:
+14044791095
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
4/2006 | Xenon Pharmaceuticals | Private Equity Round | 0 |
4/1999 | Netcentives | Private Equity Round | 0 |
8/2021 | Aumni | Series B | 50M |
2/2008 | Touchdown Technologies | Series D | 0 |
4/2022 | Copper Banking | Series A | 0 |
1/2015 | SpaceX | Series G | 0 |
11/2021 | Hum Capital | Series A | 12M |
5/2022 | Flowcarbon | Series A | 0 |
8/2021 | Abogen Biosciences | Series C | 0 |
5/2022 | Flowcarbon | Series A | 0 |
4/2022 | Copper Banking | Series A | 0 |
11/2021 | Hum Capital | Series A | 0 |
8/2021 | Aumni | Series B | 0 |
8/2021 | Abogen Biosciences | Series C | 0 |
1/2015 | SpaceX | Series G | 0 |
2/2008 | Touchdown Technologies | Series D | 0 |
4/2006 | Xenon Pharmaceuticals | Private Equity Round | 0 |
4/1999 | Netcentives | Private Equity Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|